|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage Ⅱ and Ⅲ colon cancer:results of a randomized trial显示文摘 | Andre T Colin P Louver C | 2003 | J Clin Oncol2003，21，15： | 1 |
| 2 | Phase Ⅱ study of oxalipltfin,fluorouracfl,and folinic acid in locally advanced or metastatic gastric cancer patients显示文摘 | Louver C André T Tigaud JM | 2002 | J Clin Oncol2002，20，23： | 1 |
| 3 | High dose intensity oxaliplatian added to the simplified bimonthly leucororin and 5-fluorouraeil regimen as second-line therapy for metastatic colorectal cancer(FOLFOX)显示文摘 | Maindrault Goebel F de-Gramout A Louver C | 2001 | Eur J Cancer2001，37，8： | 1 |
| 4 | Co Ion can cer: wh at is new in 2004显示文摘 | And re T Louver C G ram on tA | 2004 | Bull Can cer2004，91，1： | 1 |
| 5 | Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase Ⅱ study 显示文摘 | Louver C Andre T Lledo G | 2002 | J Clin Oncol2002，20，16： | 1 |
| 6 | Gemcitabine in com- bination with oxaliplatin compared with gemcitahine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial 显示文摘 | Louver C Labianca R Hammel P | 2005 | J Clin Oncol2005，23，15： | 1 |
| 7 | Phase Ⅱ study of oxaliplatin,fluorouracil,and folinic acid in locally advanced or metastatic gastric cancer patients显示文摘 | Louver C André T Tigand JM | | 0，，23： | 1 |
| 8 | An immunomodulatory role for follistatin-like 1 in heart allograft transplantation显示文摘 | Le LJB Condamine T Louver C | 2008 | Am J Transplant2008，8，11： | 1 |
| 9 | Role and value of oxaliplatin in metastatic colorectal cancers显示文摘 | Louver C de Gramont A | | 0，，4： | 1 |
| 10 | Phase Ⅱ study of Oxali platin , fluorouracil,and folinic acid in locally advanced or meta2 static gastric cancer patient s显示文摘 | Louver C Andre T Tigaud JM | 2002 | J Clin Oncol2002，20，23： | 1 |
| 11 | A review of GERCOD trials of bimonthly leueovofin plus 5 - fluorouraeil 48 h continuous infusion in advanced eolorectal cancer: evolution of a regimen 显示文摘 | De Grmnont A Louver C Andre T | 1998 | Eur J Cancer1998，34，61： | 1 |
| 12 | Phase II sludy of oxaliplatin, flurouracil, and folinic acid in locally advanced or metastatic gastric cancer patients显示文摘 | Louver C Andre T Tigaud J M | 2002 | J Clin Oncol2002，20，23： | 1 |
| 13 | A review of GERCOD trials of bimonthly leucovorln plus 5-fluorouracil 48 h continuces infusion in advanced colorectal cancer: evolution of a regimen显示文摘 | De Gramont Louver C Andre T | 1998 | Eur J Cancer1998，34，5： | 1 |
| 14 | Antitumour activity of pemetrexed(Peru) and irinotecan (Iri)in second-line metastatic colorectal cancer(MCRC)patients:A muhicenter phaseⅡ study显示文摘 | Louver C Andre T Gamelin E | 2007 | J Clin Oncol2007，25，18： | 1 |
| 15 | High-dose intensity oxaliplation added to the simplified bimonfldy hu-cororin and 5-fluorouracil regimen as second-line therapy for me-ltstatic colorectal cancer (FOLFOX)显示文摘 | Maindrault Goebel F de-Gramout A Louver C | 2001 | Eur J Cancer2001，37，10： | 1 |
| 16 | High dose intensity oxaliplation added to the simplified bimonthly leucororin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX)显示文摘 | Maindrault Goebel F de-GramoutA Louver C | 2001 | Eur J Cancer2001，37，8： | 1 |
| 17 | Phase Ⅱ study of oxalip latin, Fluorouracil, and Folonic Acid in locally advanced or metastatic gastric cancer patients 显示文摘 | Louver C Andre T Tigaud JM | 2002 | J Clin Oncol2002，20，23： | 1 |
| 18 | High dose intensity oxaliplatin added to the simplified bimonthly leucororin and 5-fluorouracil regimen as second line therapy for metastatic colorectal cancer (FOLFOX)显示文摘 | Maindrauly Goebel F de-Gramout A Louver C | 2001 | Eur J Cancer2001，37，8： | 1 |
| 19 | Phase study of oxali-platin, fluorouracil, and folinicacid in locally advanced or metastatic gastric cancer patients显示文摘 | Louver C Andre T Tigaud J M | 2002 | J Clin Oncol2002，20，23： | 1 |
| 20 | Highdose intensity oxaliplation added to the simplifid bimonthly leucororin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX)显示文摘 | Maindrault Goebel F de-Gramout A Louver C | 2001 | Eur J Cancer2001，37，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员